Ribonucleolytic activity of mycoplasmas

• Published in: Microbiology (New York) 2014-05, Vol.83 (3), p.247-254
• Main Authors: Ilinskaya, O. N., Sokurenko, Yu. V., Ul’yanova, V. V., Vershinina, V. I., Zelenikhin, P. V., Kolpakov, A. I., Medvedeva, E. S., Baranova, N. B., Davydova, M. N., Muzykantov, A. A., Chernova, O. A., Chernov, V. M.
• Format: Article
• Language: English
• Subjects: Acholeplasma laidlawii; Bacillus subtilis; Biomedical and Life Sciences; Experimental Articles; Life Sciences; Medical Microbiology; Microbiology; Mycoplasma hominis
• ISSN: 0026-2617; 1608-3237
• DOI: 10.1134/S0026261714030072

Mycoplasmas are incapable of de novo synthesis of nucleotides and must therefore secrete nucleases in order to replenish the pool of nucleic acid precursors. The nucleolytic activity of mycoplasmas is an important factor in their pathogenicity. Bacterial ribonucleases (RNases) may produce a broad spectrum of biological effects, including antiviral and antitumor activity. Mycoplasma RNases are therefore of interest. In the present work, the capacity of Acholeplasma laidlawii and Mycoplasma hominis for RNase synthesis and secretion was studied. During the stationary growth phase, these organisms were found to synthesize Mg 2+ -dependent RNases, with their highest activity detected outside the cells. Localization of A. laidlawii RNases was determined: almost 90% of the RNase activity was found to be associated with the membrane vesicles. Bioinformational analysis revealed homology between the nucleotide sequences of 14 Bacillus subtilis genes encoding the products with RNase activity and the genes of the mycoplasmas under study. Amino acid sequences of 4 A. laidlawii p roteins with ribonuclease activity and the Bsn RNase were also established.